About
Dr. Theodore Blackwood has spent two decades optimizing pharmacokinetic profiles of therapeutic peptides at UPenn. His depot formulation patents underpin three commercial products.
Summary
Recognized authority on extending peptide half-life through chemical modification and formulation engineering.
Key Lessons
A near-miss with an unstable peptide formulation in 2017 drove him to create the systematic stability screening protocol adopted industry-wide.
Certifications
- Pharm.D., UPenn
- Board Certified Pharmacotherapy Specialist
- ACCP Fellow
Areas of Expertise
- Peptide half-life optimization
- Depot formulation design
- PK/PD modeling